Search Results - "BOSCHELLI, Frank"

Refine Results
  1. 1
  2. 2

    SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells by Vultur, Adina, Buettner, Ralf, Kowolik, Claudia, Liang, Wei, Smith, David, Boschelli, Frank, Jove, Richard

    Published in Molecular cancer therapeutics (01-05-2008)
    “…Src family kinase activity is elevated in many human tumors, including breast cancer, and is often associated with aggressive disease. We examined the effects…”
    Get full text
    Journal Article
  3. 3
  4. 4

    SKI-606 (Bosutinib) blocks prostate cancer invasion, growth, and metastasis in vitro and in vivo through regulation of genes involved in cancer growth and skeletal metastasis by Rabbani, Shafaat A, Valentino, Maria-Luisa, Arakelian, Ani, Ali, Suhad, Boschelli, Frank

    Published in Molecular cancer therapeutics (01-05-2010)
    “…In the current study, we have examined the efficacy of a Src/Abl kinase inhibitor SKI-606 (Bosutinib) for its effect on prostate cancer growth and skeletal…”
    Get full text
    Journal Article
  5. 5

    Discovery of Benzisoxazoles as Potent Inhibitors of Chaperone Heat Shock Protein 90 by Gopalsamy, Ariamala, Shi, Mengxiao, Golas, Jennifer, Vogan, Erik, Jacob, Jaison, Johnson, Mark, Lee, Frederick, Nilakantan, Ramaswamy, Petersen, Roseann, Svenson, Kristin, Chopra, Rajiv, Tam, May S, Wen, Yingxia, Ellingboe, John, Arndt, Kim, Boschelli, Frank

    Published in Journal of medicinal chemistry (14-02-2008)
    “…Heat shock protein 90 (Hsp90) is a molecular chaperone that is responsible for activating many signaling proteins and is a promising target in tumor biology…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT) by Ozawa, Yukiyasu, Williams, Ann H, Estes, Myka L, Matsushita, Norimasa, Boschelli, Frank, Jove, Richard, List, Alan F

    Published in Leukemia research (01-06-2008)
    “…Abstract We investigated the role of Src family kinases (SFKs) in the regulation of STAT activation in myeloid leukemia cells. Two of 6 AML cell lines…”
    Get full text
    Journal Article
  10. 10

    Synthesis and Src Kinase Inhibitory Activity of a Series of 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles by Boschelli, Diane H, Wu, Biqi, Ye, Fei, Wang, Yan, Golas, Jennifer M, Lucas, Judy, Boschelli, Frank

    Published in Journal of medicinal chemistry (28-12-2006)
    “…Compound 1 (SKI-606, bosutinib), a 7-alkoxy-4-[(2,4-dichloro-5-methoxyphenyl)amino]-3-quinolinecarbonitrile, is a potent inhibitor of Src kinase activity. We…”
    Get full text
    Journal Article
  11. 11

    Identification of a Conserved Sequence Motif That Promotes Cdc37 and Cyclin D1 Binding to Cdk4 by Zhao, Qiang, Boschelli, Frank, Caplan, Avrom J., Arndt, Kim T.

    Published in The Journal of biological chemistry (26-03-2004)
    “…Cdc37 is a molecular chaperone that is important for the stability and activity of several protein kinases, including Cdk4 and Raf1. We first determined, using…”
    Get full text
    Journal Article
  12. 12

    Synthesis and Src Kinase Inhibitory Activity of a Series of 4-Phenylamino-3-quinolinecarbonitriles by Boschelli, Diane H, Wang, Yanong D, Ye, Fei, Wu, Biqi, Zhang, Nan, Dutia, Minu, Powell, Dennis W, Wissner, Allan, Arndt, Kim, Weber, Jennifer M, Boschelli, Frank

    Published in Journal of medicinal chemistry (01-03-2001)
    “…Screening of a directed compound library in a yeast-based assay identified 4-[(2,4-dichlorophenyl)amino]-6,7-dimethoxy-3-quinolinecarbonitrile (2a) as a Src…”
    Get full text
    Journal Article
  13. 13

    Bosutinib: A review of preclinical studies in chronic myelogenous leukaemia by Boschelli, Frank, Arndt, Kim, Gambacorti-Passerini, Carlo

    Published in European journal of cancer (1990) (01-07-2010)
    “…Abstract Bosutinib (SKI-606) is an orally active Src and Abl kinase inhibitor presently in Phase III trials for treatment of chronic myelogenous leukaemia…”
    Get full text
    Journal Article
  14. 14

    A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo by JALLAL, Houda, VALENTINE, Maria-Luisa, GAOPING CHEN, BOSCHELLI, Frank, ALI, Suhad, RABBANI, Shafaat A

    Published in Cancer research (Chicago, Ill.) (15-02-2007)
    “…The central role of Src in the development of several malignancies, including breast cancer, and the accumulating evidence of its interaction with receptor…”
    Get full text
    Journal Article
  15. 15

    In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib by Redaelli, Sara, Perini, Pietro, Ceccon, Monica, Piazza, Rocco, Rigolio, Roberta, Mauri, Mario, Boschelli, Frank, Giannoudis, Athina, Gambacorti-Passerini, Carlo

    Published in Journal of hematology and oncology (07-07-2015)
    “…Bosutinib is a recently approved ABL inhibitor. In spite of the well-documented effectiveness of BCR-ABL inhibitors in treating chronic myeloid leukemia,…”
    Get full text
    Journal Article
  16. 16
  17. 17

    SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models by GALAS, Jennifer M, LUCAS, Judy, FANGBIAO LI, TITSCH, Craig, HUSELTON, Christine, CHAUDHARY, Inder, BOSCHELLI, Frank, ETIENNE, Carlo, GOLAS, Jonathan, DISCAFANI, Carolyn, SRIDHARAN, Latha, BOGHAERT, Erwin, ARNDT, Kim, FEI YE, BOSCHELLI, Diane H

    Published in Cancer research (Chicago, Ill.) (15-06-2005)
    “…Src up-regulation is a common event in human cancers. In colorectal cancer, increased Src levels are an indicator of poor prognosis, and progression to…”
    Get full text
    Journal Article
  18. 18

    Valproic acid enhances bosutinib cytotoxicity in colon cancer cells by Mologni, Luca, Cleris, Loredana, Magistroni, Vera, Piazza, Rocco, Boschelli, Frank, Formelli, Franca, Gambacorti‐Passerini, Carlo

    Published in International journal of cancer (15-04-2009)
    “…Unbalanced histone deacetylase (HDAC) hyperactivity is a common feature of tumor cells. Inhibition of HDAC activity is often associated with cancer cell growth…”
    Get full text
    Journal Article
  19. 19
  20. 20